HCV, HIV, or HDV coinfection.
HCC or other malignancy within 3 years.
Decompensated liver cirrhosis (CTP score = 7).
Uremia patients under hemodialysis or continuous ambulatory peritoneal dialysis or patients with Ccr < 50 mL/min
Pregnant or breastfeeding women.
Women of child-bearing potential (WOCBP) who are unwilling or unable to use an acceptable method of contraception to avoid pregnancy throughout the study and for up to 4 weeks after the last dose of study drug.
